S&P 500   5,086.21 (-0.05%)
DOW   39,152.44 (+0.05%)
QQQ   437.46 (+0.16%)
AAPL   181.13 (-0.76%)
MSFT   408.91 (-0.35%)
META   483.11 (-0.19%)
GOOGL   139.04 (-3.42%)
AMZN   175.21 (+0.13%)
TSLA   200.85 (+4.63%)
NVDA   798.92 (+1.36%)
NIO   5.59 (+3.52%)
AMD   177.24 (+0.41%)
BABA   76.07 (+0.14%)
T   16.64 (-0.95%)
F   12.09 (-0.41%)
MU   91.38 (+6.26%)
CGC   3.47 (+3.27%)
GE   154.51 (+0.77%)
DIS   108.40 (+0.61%)
AMC   4.50 (+1.35%)
PFE   27.22 (-1.95%)
PYPL   59.94 (+1.32%)
XOM   104.58 (+0.71%)
S&P 500   5,086.21 (-0.05%)
DOW   39,152.44 (+0.05%)
QQQ   437.46 (+0.16%)
AAPL   181.13 (-0.76%)
MSFT   408.91 (-0.35%)
META   483.11 (-0.19%)
GOOGL   139.04 (-3.42%)
AMZN   175.21 (+0.13%)
TSLA   200.85 (+4.63%)
NVDA   798.92 (+1.36%)
NIO   5.59 (+3.52%)
AMD   177.24 (+0.41%)
BABA   76.07 (+0.14%)
T   16.64 (-0.95%)
F   12.09 (-0.41%)
MU   91.38 (+6.26%)
CGC   3.47 (+3.27%)
GE   154.51 (+0.77%)
DIS   108.40 (+0.61%)
AMC   4.50 (+1.35%)
PFE   27.22 (-1.95%)
PYPL   59.94 (+1.32%)
XOM   104.58 (+0.71%)
S&P 500   5,086.21 (-0.05%)
DOW   39,152.44 (+0.05%)
QQQ   437.46 (+0.16%)
AAPL   181.13 (-0.76%)
MSFT   408.91 (-0.35%)
META   483.11 (-0.19%)
GOOGL   139.04 (-3.42%)
AMZN   175.21 (+0.13%)
TSLA   200.85 (+4.63%)
NVDA   798.92 (+1.36%)
NIO   5.59 (+3.52%)
AMD   177.24 (+0.41%)
BABA   76.07 (+0.14%)
T   16.64 (-0.95%)
F   12.09 (-0.41%)
MU   91.38 (+6.26%)
CGC   3.47 (+3.27%)
GE   154.51 (+0.77%)
DIS   108.40 (+0.61%)
AMC   4.50 (+1.35%)
PFE   27.22 (-1.95%)
PYPL   59.94 (+1.32%)
XOM   104.58 (+0.71%)
S&P 500   5,086.21 (-0.05%)
DOW   39,152.44 (+0.05%)
QQQ   437.46 (+0.16%)
AAPL   181.13 (-0.76%)
MSFT   408.91 (-0.35%)
META   483.11 (-0.19%)
GOOGL   139.04 (-3.42%)
AMZN   175.21 (+0.13%)
TSLA   200.85 (+4.63%)
NVDA   798.92 (+1.36%)
NIO   5.59 (+3.52%)
AMD   177.24 (+0.41%)
BABA   76.07 (+0.14%)
T   16.64 (-0.95%)
F   12.09 (-0.41%)
MU   91.38 (+6.26%)
CGC   3.47 (+3.27%)
GE   154.51 (+0.77%)
DIS   108.40 (+0.61%)
AMC   4.50 (+1.35%)
PFE   27.22 (-1.95%)
PYPL   59.94 (+1.32%)
XOM   104.58 (+0.71%)

Navidea Biopharmaceuticals (NAVB) Social Media Sentiment and Mentions

$0.04
-0.01 (-15.33%)
(As of 11:34 AM ET)

Media Mentions Over Time



View Trending Media Stocks
Recieve Navidea Biopharmaceuticals News and Ratings via Email

Sign-up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter.

NAVB Social Media Mentions



Related Companies and Tools

This page (NYSE:NAVB) was last updated on 2/26/2024 by MarketBeat.com Staff